Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells.

MLA

Komedchikova, Elena N., et al. “Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells.” Pharmaceutics, vol. 15, no. 1, Dec. 2022. EBSCOhost, https://doi.org/10.3390/pharmaceutics15010052.

APA

Komedchikova, E. N., Kolesnikova, O. A., Tereshina, E. D., Kotelnikova, P. A., Sogomonyan, A. S., Stepanov, A. V., Deyev, S. M., Nikitin, M. P., & Shipunova, V. O. (2022). Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells. Pharmaceutics, 15(1). https://doi.org/10.3390/pharmaceutics15010052

Chicago

Komedchikova, Elena N, Olga A Kolesnikova, Ekaterina D Tereshina, Polina A Kotelnikova, Anna S Sogomonyan, Alexey V Stepanov, Sergey M Deyev, Maxim P Nikitin, and Victoria O Shipunova. 2022. “Two-Step Targeted Drug Delivery via Proteinaceous Barnase-Barstar Interface and Doxorubicin-Loaded Nano-PLGA Outperforms One-Step Strategy for Targeted Delivery to HER2-Overexpressing Cells.” Pharmaceutics 15 (1). doi:10.3390/pharmaceutics15010052.